Wellington Shields Capital Management, LLC Pfizer Inc Transaction History

Wellington Shields Capital Management, LLC

$1.23 Billion
Q4 2024

A detailed history of Wellington Shields Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 24,019 shares of PFE stock, worth $639,866. This represents 0.05% of its overall portfolio holdings.

Number of Shares

24,019

Previous 29,730 19.21%

Holding current value

$639,866

Previous $860,000 25.93%

% of portfolio

0.05%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $141,632 - $172,415	-5,711 Reduced 19.21%	24,019 $637,000
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $16,149 - $18,300	-583 Reduced 1.92%	29,730 $860,000
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $11,038 - $12,935	-437 Reduced 1.42%	30,313 $848,000
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $9,967 - $11,446	385 Added 1.27%	30,750 $853,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $56,388 - $73,242	-2,158 Reduced 6.64%	30,365 $874,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $322,825 - $377,350	10,060 Added 44.78%	32,523 $1.08 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $46,486 - $53,783	-1,287 Reduced 5.42%	22,463 $823,000
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $278,093 - $362,036	-7,060 Reduced 22.91%	23,750 $968,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $6,012 - $7,848	-144 Reduced 0.47%	30,810 $1.58 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1,881 - $2,297	-43 Reduced 0.14%	30,954 $1.36 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $768,396 - $911,077	-16,514 Reduced 34.76%	30,997 $1.63 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $1.1 Million - $1.37 Million	-24,107 Reduced 33.66%	47,511 $2.47 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $722,397 - $1.07 Million	17,483 Added 32.3%	71,618 $4.23 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $963,862 - $1.24 Million	-24,557 Reduced 31.21%	54,135 $2.33 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $543,066 - $615,203	-15,123 Reduced 16.12%	78,692 $3.08 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $366,748 - $413,619	-10,951 Reduced 10.45%	93,815 $3.4 Million
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $247,845 - $315,156	7,405 Added 7.61%	104,766 $3.86 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $49,085 - $57,588	-1,546 Reduced 1.56%	97,361 $3.57 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $97,106 - $117,804	3,224 Added 3.37%	98,907 $3.23 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $81,035 - $115,782	-2,998 Reduced 3.04%	95,683 $3.12 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $80,950 - $91,868	-2,459 Reduced 2.43%	98,681 $3.87 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $308,525 - $400,066	9,496 Added 10.36%	101,140 $3.63 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $123,587 - $138,759	-3,342 Reduced 3.52%	91,644 $3.97 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $453,937 - $498,726	-12,105 Reduced 11.3%	94,986 $4.03 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $26,390 - $30,087	-686 Reduced 0.64%	107,091 $4.68 Million
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $2,861 - $3,470	83 Added 0.08%	107,777 $4.75 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $296 - $316	9 Added 0.01%	107,694 $3.91 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $9,636 - $11,180	-302 Reduced 0.28%	107,685 $3.82 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $129,414 - $137,313	-3,891 Reduced 3.48%	107,987 $3.91 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $3.47 Million - $3.82 Million	111,878	111,878 $3.99 Million

Others Institutions Holding PFE

# of Institutions

3,370

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account

Wellington Shields Capital Management, LLC Pfizer Inc Transaction History